Details of the Drug Formulations

General Information of Drug (ID: DM1XT4N)

Drug Name
Tafenoquine Drug Info
Synonyms 106635-80-7; WR-238605; WR 238605; Etaquine; WR238605; Tafenoquine [INN:BAN
Indication
Disease Entry ICD 11 Status REF
Malaria 1F40-1F45 Approved [1]
Plasmodium vivax malaria 1F41 Approved [1]
Cross-matching ID
PubChem CID
115358
ChEBI ID
CHEBI:141487
CAS Number
106635-80-7
TTD ID
D07TWN
INTEDE ID
DR1526
ACDINA ID
D01454

Full List of Drug Formulations Containing This Drug

Tafenoquine 150 mg tablet
Company Formulation ID FDA Description
Glaxosmithkline F23913 Magnesium Stearate; Mannitol; Microcrystalline Cellulose; Hydroxypropylmethylcellulose; Polyethylene Glycol; Red Iron Oxide; Titanium Dioxide
------------------------------------------------------------------------------------
Tafenoquine 100 mg tablet
Company Formulation ID FDA Description
60 Degrees Pharmaceuticals F23914 Magnesium Stearate; Mannitol; Microcrystalline Cellulose; Hypromellose; Iron Oxide Red; Macrogol/Polyethylene Glycol; Titanium Dioxide
------------------------------------------------------------------------------------

References

1 Tafenoquine: First Global Approval.Drugs. 2018 Sep;78(14):1517-1523.